Order Now, Ships Today
$200.00
One-time
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Quality controlled from start to finish.
No outsourcing.
Research suggests this investigational peptide, among Cagrilintide peptides studied in metabolic research, may interact with the calcitonin receptor with potentially enhanced pharmacokinetic properties. Studies indicate it may influence cellular signaling through three primary mechanisms: receptor interaction, cellular processes, and what appears to be observed in gastric activity. Preliminary clinical data suggests there may be notable laboratory measurements, particularly in type 2 diabetes contexts. The compound’s modified structure may exhibit different stability profiles compared to native amylin, potentially allowing for sustained receptor interaction. Current investigations are assessing its possible applications in obesity and metabolic research. The Cagrilintide compound requires proper reconstitution prior to administration according to laboratory protocols.
